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Abstract
Background: Few studies have described patients with foregut dysmotility in inflammatory bowel 
disease. The aim of this case series was to evaluate clinical characteristics of 5 patients with 
inflammatory bowel disease and symptoms and signs of upper gut dysmotility.
Case presentations: We describe a series of four patients with Crohn's disease and one with 
indeterminate colitis who presented with severe symptoms and signs of gastroparesis. We 
reviewed medical records of all cases. Gastric emptying of a solid meal was assessed by scintigraphy. 
Small bowel enteroclysis, gastroduodenoscopy and colonoscopy with biopsies were performed to 
estimate the activity of the disease and to exclude organic obstruction. None of the patients had 
any signs of active inflammation or stricture. All of the patients had markedly delayed gastric 
emptying with a mean t l/2 of 234 minutes (range ll0-380 minutes; normal values 54-94 minutes).
Conclusion: Clinicians should consider impaired gastric emptying when evaluating patients with 
Crohn's disease and severe symptoms of upper gut dysmotility, which cannot be attributed to 
active inflammation or organic obstruction of the digestive tract. Symptoms in these patients are 
refractory to various therapeutic interventions including tube feeding and gastric surgery.
Background
Crohn's disease is a chronic inflammatory condition of 
unknown aetiology, which may involve the whole diges­
tive tract from the oral cavity to the anus. Symptoms indic­
ative of gastroparesis, such as vomiting and bloating do 
occur in patients with Crohn's disease, but recurrent and/ 
or persistent symptoms are rare and most clinicians 
attribute them to active inflammation or mechanical 
obstruction of the small or large bowel. Though local 
inflammation and intestinal obstruction may have impor­
tant effects on gastrointestinal motility, motility studies in 
patients with Crohn's disease are scant [1,2]. Some reports
indicate that upper gut motility can be impaired in 
patients with inactive Crohn's disease [1,3].
The aim of this case series is to describe clinical character­
istics of five patients (four patients with inactive Crohn's 
disease and a single patient with indeterminate colitis) 
who had severe symptoms of gastroparesis which could 
not be attributed to mechanical obstruction or active 
inflammation, but who all had impaired gastric emptying 
of solid food.
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Case presentation
The patients were all treated in our institute which is a ter­
tiary referral centre for inflammatory bowel disease (IBD) 
in the Netherlands. We identified patients by a search of 
the morbidity database of the department of Gastroenter­
ology and Hepatology which includes the ICD-9 diag­
noses of975 patients with Crohn's disease and 821 
patients with colitis ulcerosa referred between 1973 and 
2004 and by a search of the gastric emptying database 
which includes 239 patients who underwent a scinti­
graphic gastric emptying study in our hospital between 
1999 and 2004. We selected cases with a diagnosis of IBD 
including Crohn's disease and ulcerative colitis who also 
had an impaired gastric emptying by matching the two 
data bases. We identified four patients with Crohn's dis­
ease and one with indeterminate colitis who were diag­
nosed based upon accepted radiological, endoscopic and 
histological criteria [4]. We have reviewed the medical 
records of the cases who all had a severe symptoms of 
foregut dysmotility.
Because of persistent symptoms of nausea, vomiting and 
in some cases weight loss patients were thoroughly evalu­
ated. All patients underwent a small bowel enteroclysis. 
None of the patients had signs of active inflammation or 
stricture. Colonoscopy with inspection of the terminal 
ileum was performed in every patient and biopsy speci­
mens were taken for pathological examination. All 
patients underwent an upper gastrointestinal endoscopy 
to rule out active Crohn's disease in the upper digestive 
tract and intestinal stenosis as cause of the symptoms. 
Random biopsies were taken from the gastric antrum and 
corpus. We found no mechanical obstruction in any of the 
patients and there were no endoscopical or histological 
signs of active Crohn's disease. Furthermore there were no 
signs of inflammation in the laboratory studies. After hav­
ing ruled out active inflammatory disease gastric empty­
ing was evaluated by a scintigraphy in all patients.
Table 1 summarizes clinical data of all patients. Remarka­
bly all of them were females with a mean age of 38.6 years 
at the time of impaired gastric emptying (range 21 -  56 
years). The mean duration of the disease was 9.4 years 
with a wide range from 2 to 26 years. One patient had 
small bowel involvement, in two the disease involved the 
small bowel and the colon, and in two it was limited to 
the colon. Two of the patients had undergone resection, 
colectomy with ileostomy (patient 4) and ileum resection 
twice (patient 2). Despite discouragement, three of the 
patients were smoking. The mean t 1/2 of gastric emptying 
was 234 minutes (range 110-380 minutes).
We describe one of the cases (case1) in more detail. This 
was a 19-yr-old female patient with a history of asthma 
presented to our outpatient clinic with complaints of 
abdominal pain and chronic diarrhea that had been 
present for approximately 5 months. She complained of 
continuous pain localized in the upper abdomen but she 
also had intermittent colic-like pain elicited by food 
ingestion, sometimes accompanied by nausea. There was 
watery diarrhea with a frequency of up to 10 times a day. 
She had anorexia and lost 15 kg of weight in the preceding 
5 months. She had been taking diclofenac and she 
smoked 4 cigarettes per day.
On physical examination she had normal vital signs. Her 
weight was 84 kg with a length of 171 cm. There was a 
mild tenderness in the right lower abdomen. Further 
examination was not remarkable.
Initial laboratory studies revealed a sedimentation rate of 
25 mm in the 1st hr, C-reactive protein of 40 mg/L, albu­
min 37 g/L (normal 36-53 g/L), haemoglobin was 7.8 
mmol/L (normal 7.3-9.7 mmol/L), white cell count was 
12.1 x 109/L (normal 3.5-11.0 x 109/L) with 75% neu­
trophils and thrombocytes were elevated (480 x 109/L; 
normal 120-350 x 109/L). Sigmoidoscopy revealed a 
patchy erythema with rectal sparing. Histopathology of 
the biopsy specimen showed chronic active inflammation
T a b le  1: C lin ic a l d a ta  o f  th e  five  p a tie n ts
Patients 1 2 3 4 5
Diagnosis CD CD CD CD IC
Sex F F F F F
A ge (y r) 21 29 38 56 57
Age at diagnosis (yr) 19 23 28 30 54
BMI (kg/m2) 37,4 33 31,4 22,3 19
Localisation Ileum-Colon Ileum Ileum-Colon Colon Colon
Resection N o Ileum x 2 N o C olectom y No
Stomy N o N o N o Ileostomy No
Smoking Yes Yes Yes N o N o
T l/2  (min) 380 288 220 110 171
C D, Crohn's disease; IC, indeterm inate colitis; BMI, body mass index
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without presence of granulomas. Barium examination of 
the small bowel demonstrated a narrowing of the distal 
ileum with thickening of the wall over a length of 40 cm.
A diagnosis of Crohn's disease with involvement of left 
colon and terminal ileum was made and treatment was 
started with oral corticosteroids and azathioprine in com­
bination with mesalazine. Because of adverse reaction 
(fever) to azathioprine and thereafter mercaptopurine, 
tioguanine was prescribed, and well tolerated.
One year and a half after the first presentation she com­
plained of nausea, vomiting, early satiety, weight loss of 
15 kg and diarrhea. Laboratory studies now showed no 
signs of inflammation. There were no endoscopic signs of 
activity of Crohn's disease in colon, terminal ileum or 
stomach and duodenum. Biopsy specimens taken from 
the gastric antrum, duodenum, terminal ileum and colon 
revealed no active inflammation. Small bowel enterocly- 
sis showed no stricture and the terminal ileum was now 
normal. Gastric emptying with radiolabeled pancake was 
severely delayed with a t 1/2 of 200 minutes and 3 months 
later with a t 1/2 of 380 minutes.
Tioguanine was stopped because of the remote possibility 
that the symptoms were secondary to the drugs, but this 
did not ameliorate the symptoms. Because of persistent 
foregut dysmotility symptoms nasojejunal feeding was 
initiated. Recently she underwent a Roux-Y gastrojejunos­
tomy with introduction of an enterocutaneous jejunal 
feeding catheter.
T re a tm e n t and prognosis
Patient 1 is the only patient who underwent surgery 
because of her foregut dysmotility. The surgical procedure 
was recently performed but at present the gastroenteros­
tomy fails to improve her symptoms. Patient 4 was only 
treated with oral prokinetics that had a partial effect while 
all other patients also received nasogastric 24 hour contin­
uous drip tube feeding. One of these three patients 
(patient 3) underwent a percutaneous endoscopic gastros­
tomy tube (PEG) placement, which was removed two 
months later for psychological reasons. Despite these 
interventions, symptoms of upper gut dysmotility persist 
in all patients.
Discussion
This report describes five patients with clinically inactive 
inflammatory bowel disease who presented with persist­
ent severe complaints of upper gastrointestinal motility 
disorder. All patients had disabling upper gastrointestinal 
symptoms with weight loss which in most of the cases led 
to invasive treatment including nasogastric tube feeding, 
PEG and even gastrojejunostomy with placement of a 
jejunostomy catheter.
Reports on delayed gastric emptying in Crohn's disease 
are scarce. Annese et al studied gastric emptying in 21 
adult patients with nonobstructive Crohn's disease [2]. 
Gastric emptying was not different from that in healthy 
volunteers. Only posthoc analysis revealed impaired gas­
tric emptying in a subgroup of patients who complained 
of mild upper gut symptoms such as bloating, early satiety 
and abdominal distention and in those with localization 
restricted to the colon [2]. Our case series extends these 
findings and shows that delayed gastric emptying in inac­
tive Crohn's disease may induce serious upper gut symp­
toms prompting clinicians for elaborate diagnostic 
investigations including upper gut endoscopy and assess­
ment of gastric emptying. Our series shows that delayed 
gastric emptying is not confined to patients with localiza­
tion restricted to the colon.
Why do patients with Crohn's disease develop symptoms 
of foregut dysmotility? It is logical to infer that active 
Crohn's disease with accompanying intestinal inflamma­
tion has functional ramifications. Contraction of smooth 
muscle from inflamed small intestine derived from 
patients with Crohn's disease is abnormal [3]. Distal 
motility disturbances due to ileal or colonic inflammation 
might subsequently impair gastric emptying, a phenome­
non similar to that in patients with slow transit constipa­
tion [5,6]. Likewise, obstruction of the small bowel or 
colon due to Crohn's disease can cause foregut dysmotil- 
ity. Moreover, gastric Crohn's disease impairs gastric emp­
tying which can be observed in up to 70% of cases, but 
this is more often seen in children as compared to adults 
[7-9]. None of patients described in this report had signs 
of active disease. Enteroclysis, colonoscopy, endoscopy of 
the upper gut with bioptic samples and laboratory studies 
were compatible with absence of active inflammation in 
all patients.
Two of our patients had a history of intestinal resection. 
However, surgical resections are not associated with a det­
rimental effect on gastric emptying in patients with 
Crohn's disease [10].
Antroduodenal manometry studies have also shown that 
upper gastrointestinal motor disorders occur in up to 74% 
of patients with uncomplicated Crohn's disease [1]. We 
did not perform an antroduodenal manometry in any of 
the patients in this case series.
The explanation for the foregut dysmotility and the 
related symptoms of our patients is not clear. It is possible 
that there is a minor degree of intestinal fibrosis without 
radiological signs of obstruction or inflammation of the 
bowel that cannot be detected with standard clinical 
methods. On the other hand, the gastrointestinal motility 
is regulated by gut hormones, of which peptide YY (PYY)
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is the most prominent member [11]. Circulating PYY 
inhibits gastric emptying [12,13]. It has been shown that 
patients with Crohn's disease have elevated serum levels 
of PYY [14], which could be a possible explanation for 
upper gastrointestinal motility disturbance in these 
patients. Lastly, Porcher et al [15] reported that interstitial 
cells of Cajal were abundant in the small intestine of 
patients with Crohn's disease and reasoned that this could 
lead to desynchronization of electrical pacemaker activity. 
This might be due to invasion of the external muscle lay­
ers by inflammatory cells.
Conclusion
We describe five patients with Crohn's disease who had 
no signs of active inflammation but developed severe 
symptoms of gastroparesis. It remains to be elucidated 
why some patients with inactive Crohn's disease develop 
upper gut motor disturbances. According to our experi­
ence these patient will develop persistent symptoms 
despite medical treatment. Tube feeding is most often nec­
essary and even bypassing of the stomach seems to be the 
only therapeutic possibility in the most extreme cases.
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